This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cataract or Lens Opacity
and you are
over 50
years old
The phase for this study is not defined.
Show me locations

The purpose

This is a prospective, non-randomised, controlled, single-surgeon, single-center post-market clinical follow up study whereby patient undergoing routine cataract surgery will have bilateral implantation of a recently introduced TGA (Therapeutics Goods Authority, Australia) approved trifocal intraocular lens FineVision Evo (PhysIOL, Liège, Belgium). The primary and secondary effectiveness data for visual acuity, defocus curves, contrast sensitivity and any adverse events will be collected.

Provided treatments

  • Device: Implantation of IOL: PhysIOL POD F GF

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03027024. The sponsor of the trial is Beaver-Visitec International, Inc. and it is looking for 22 volunteers for the current phase.
Official trial title:
Clinical Study to Investigate Visual Performance of Hydrophobic Trifocal IOL: FineVision HP